Endocrinology Search
Endocrinology Endocrinology
hyperprolactinemia
HYPERPROLACTINEMIA
Hyperprolactinemia is the presence of elevated prolactin levels that occurs in about one-thirds of patients w/ chronic kidney disease & resolves after successful transplantation.
It may cause visual field defects or headache in both men and women.
In women, signs and symptoms include menstrual irregularity, galactorrhea, infertility, vaginal dryness, dyspareunia, loss of libido and reduction in vertebral bone density (in sustained, pronounced hyperprolactinemia).
While in men, signs and symptoms include diminished libido, hypogonadism, gonadotrophin suppression, osteopenia, decreased muscle mass, and decreased facial hair that may occur in prolonged hyperprolactinemia.

Hyperprolactinemia Diagnosis

Evaluation

  • Physiologic causes, renal failure, parasellar tumors, hypothyroidism and drug-induced hyperprolactinemia should be ruled out before extensive evaluation

Measure Fasting Prolactin (PRL) Level

  • Normal range: <30 ng/mL normal fasting prolactin (PRL) level
  • Diagnostic range: >250 ng/mL (with physiologic causes and drug-induced causes ruled out) usually indicates prolactinoma
    • A prolactinoma is less likely with prolactin (PRL) level <100 ng/mL
    • Several measurements should be made to confirm diagnosis

Radiologic Evaluation

  • Should be performed if there is no obvious cause of hyperprolactinemia and if tumor is suspected
    • Physician must decide whether a radiographic study is warranted if prolactin (PRL) level <250 ng/mL but >100 ng/mL
  • Magnetic resonance imaging (MRI) with gadolinium enhancement is the imaging study of choice
    • Computed tomography (CT) with contrast may also be used
    • Serum prolactin (PRL) >200 ng/mL indicates prolactinoma
      • Prolactinomas are classified as macroadenoma if the size is ≥10 mm; microadenoma if <10 mm in size
    • Serum prolactin (PRL) <200 ng/mL with large pituitary mass usually indicates hyperprolactinemia secondary to stalk compression
    • Magnetic resonance imaging (MRI) and computed tomography (CT) scan normal and no obvious cause, patient is said to have idiopathic hyperprolactinemia

Laboratory Tests

  • To establish the diagnosis of hyperprolactinemia, it is recommended to have a single measurement of serum prolactin
    • A level above the upper limits confirms the diagnosis
  • Careful history and physical exam including cranial nerve examination
    • Check for galactorrhea, visual field defects, signs of cirrhosis, hair growth pattern on the body, etc
    • Drug history
  • Blood chemistry [blood urea nitrogen (BUN), creatinine]
  • Other pituitary hormones (eg testosterone levels, cortisol, insulin growth factor-1) as necessary
  • Pregnancy test
  • To rule out macroprolactinemia, polyethylene glycol precipitation is recommended
  • Thyroid function tests (to rule out hypothyroidism)
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Low-carb diet ups energy expenditure during weight loss maintenance
Stephen Padilla, 28 Nov 2018
A low-carbohydrate diet increases energy expenditure during weight loss maintenance, consistent with the carbohydrate-insulin model, a study has shown. This metabolic effect may contribute to the success of obesity treatment, particularly among those with high insulin secretion.
Does spacing pregnancies help women with gestational diabetes?
Elvira Manzano, 5 days ago
Women with a history of gestational diabetes were 50 percent more likely to have a short interval between pregnancies compared to women without the condition, suggests a new study.
Liraglutide add-on to metformin sustained glycaemic control in T2D
Elaine Soliven, 06 Jul 2020
Adding liraglutide to metformin led to a significantly longer duration of glycaemic control in patients with type 2 diabetes (T2D) compared with an oral antidiabetic drug (OAD), according to the LIRA-PRIME* study presented at ADA 2020.
Higher fasting glucose ups post-stroke mortality in Chinese diabetic patients
Natalia Reoutova, 07 Jul 2020

A hospital-based observational cohort study finds an association between higher fasting blood glucose (FBG) levels and unfavourable outcomes, including death, among Chinese patients with diabetes mellitus (DM) following acute ischaemic stroke (AIS).